Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease

Author(s): Nicoleta Alexandru, Ana Costa, Alina Constantin, Daniel Cochior, Adriana Georgescu

Journal Name: Current Stem Cell Research & Therapy

Volume 12 , Issue 2 , 2017

Become EABM
Become Reviewer


Cardiovascular diseases (CVD) are the main object of morbidity and death in the world. There are different triggers of CVD, but atherosclerosis and/or hypertension are the most usual. CVD risk factors are used as prognosticators of disease process, while the biomarkers that envisage cardiovascular risk have an important biological basis. The integration of CVD risk factors and new biomarkers can improve CVD risk stratification and disease management. The identification of microparticles (MPs) in body fluids has opened new perspectives in diagnosis, prognosis and therapy of CVD pathogenesis. MPs are submicron vesicles released from a diversity of cell types with pleiotropic biological effects on signaling among cells. They are correlated with disease state and play a major role in atherosclerosis associated with inflammation, thrombosis as well as in CVD development and progression. This review reveals many sides of MPs as risk factors, biomarkers, novel forms of intercellular communication, non-invasive potential diagnostic tools and discusses their positive and negative impact on CVD.

Keywords: Biomarkers, cardiovascular disease, diagnostic tools, microparticles.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 15 December, 2016
Page: [89 - 102]
Pages: 14
DOI: 10.2174/1574888X11666151203224058
Price: $65

Article Metrics

PDF: 55